76
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Perceived medication benefits and their association with interest in using inhaled insulin in type 2 diabetes: a model of patients’ cognitive framework

&
Pages 255-265 | Published online: 07 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hiba EL Masri, Treasure M McGuire, Mieke L van Driel, Helen Benham & Samantha A Hollingworth. (2022) Dynamics of Patient-Based Benefit-Risk Assessment of Medicines in Chronic Diseases: A Systematic Review. Patient Preference and Adherence 16, pages 2609-2637.
Read now
Shin-ichi Harashima, Akiko Nishimura & Nobuya Inagaki. (2017) Attitudes of patients and physicians to insulin therapy in Japan: an analysis of the Global Attitude of Patients and Physicians in Insulin Therapy study. Expert Opinion on Pharmacotherapy 18:1, pages 5-11.
Read now
Dilek Gogas Yavuz, Sevim Ozcan & Oguzhan Deyneli. (2015) Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens. Patient Preference and Adherence 9, pages 1225-1231.
Read now

Articles from other publishers (11)

Sophie Lebel, Brittany Mutsaers, Christina Tomei, Caroline Séguin Leclair, Georden Jones, Danielle Petricone-Westwood, Nicole Rutkowski, Viviane Ta, Geneviève Trudel, Simone Zofia Laflamme, Andrée-Anne Lavigne & Andreas Dinkel. (2020) Health anxiety and illness-related fears across diverse chronic illnesses: A systematic review on conceptualization, measurement, prevalence, course, and correlates. PLOS ONE 15:7, pages e0234124.
Crossref
Steven V. EdelmanAnastasia ErmakovaYan XiongRay SieradzanStephanie D. Taylor. (2019) Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database Study. Journal of Managed Care & Specialty Pharmacy 25:12, pages 1420-1431.
Crossref
Wesley Nuffer & Jennifer Trujillo. (2016) The Role of Inhaled Insulin in the Management of Type 2 Diabetes. Pharmacology & Pharmacy 07:04, pages 162-169.
Crossref
Moawia M. Al-Tabakha. (2015) Future prospect of insulin inhalation for diabetic patients: The case of Afrezza versus Exubera. Journal of Controlled Release 215, pages 25-38.
Crossref
Delia Hendrie, Ted R. Miller, Richard J. Woodman, Kreshnik Hoti & Jeff Hughes. (2014) Cost-Effectiveness of Reducing Glycaemic Episodes Through Community Pharmacy Management of Patients with Type 2 Diabetes Mellitus. The Journal of Primary Prevention 35:6, pages 439-449.
Crossref
António J. Almeida & Ana Grenha. 2014. Mucosal Delivery of Biopharmaceuticals. Mucosal Delivery of Biopharmaceuticals 483 498 .
Frank PetrakStephan HerpertzElmar StriddeAndreas Pfützner. (2013) Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment, Subcutaneous Insulin Injections, or Inhaled Insulin. Diabetes Technology & Therapeutics 15:8, pages 702-710.
Crossref
M. Peyrot & R. R. Rubin. (2013) Treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial. Diabetic Medicine 30:4, pages 464-467.
Crossref
M. Peyrot, A. H. Barnett, L. F. Meneghini & P.‐M. Schumm‐Draeger. (2012) Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabetic Medicine 29:5, pages 682-689.
Crossref
Lutz Heinemann. 2012. ATTD 2011 Yearbook. ATTD 2011 Yearbook 96 108 .
L. Heinemann. (2012) New ways of insulin delivery. International Journal of Clinical Practice 66, pages 35-39.
Crossref